logo

Brazil Blood Glucose Monitoring Market Size (2024 - 2029)

The Brazil Blood Glucose Monitoring Market is projected to experience significant growth over the forecast period, driven by the increased emphasis on managing diabetes, particularly in the context of COVID-19. The pandemic underscored the heightened risks faced by individuals with diabetes, prompting a greater focus on diabetes care and monitoring. Brazil's healthcare reforms and the adoption of innovative care delivery methods, such as virtual consultations and diabetes technology, have further fueled the expansion of the market. These developments reflect a broader trend towards enhanced diabetes management, which is crucial for mitigating complications associated with COVID-19 and other health threats.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research Clinical Diagnostic Devices Research Monitoring Devices Research Handheld Monitoring Devices Research Blood Glucose Monitoring Market in Brazil Market Size

Market Size of Brazil Blood Glucose Monitoring Industry

Brazil Blood Glucose Monitoring Market Summary
Study Period 2018 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 629.61 Million
Market Size (2029) USD 916.57 Million
CAGR (2024 - 2029) 7.80 %

Major Players

Brazil Blood Glucose Monitoring Market Major Players

*Disclaimer: Major Players sorted in no particular order

Brazil Blood Glucose Monitoring Market Analysis

The Brazil Blood Glucose Monitoring Market size is estimated at USD 629.61 million in 2024, and is expected to reach USD 916.57 million by 2029, growing at a CAGR of 7.80% during the forecast period (2024-2029).

One of the most significant risk factors for a severe course of COVID-19 is diabetes mellitus. This risk is believed to be influenced by several variables that are frequently present in diabetes mellitus, such as advanced age, a proinflammatory and hypercoagulable condition, hyperglycemia, and underlying comorbidities (hypertension, cardiovascular disease, chronic kidney disease, and obesity). Diabetes was quickly recognized as a risk factor for bad results during the COVID-19 pandemic. That's why managing or delaying diabetes became more important than ever before. Several studies have confirmed that chronic diseases like diabetes are associated with adverse outcomes in COVID-19 patients.

Diabetes is associated with many health complications. Comparing the population with and without diabetes, those with diabetes have a 300% increased risk of being hospitalized and, thus, incur more healthcare expenses compared to non-diabetic people. People with diabetes face a higher chance of experiencing serious complications from COVID-19. In general, people with diabetes are more likely to experience severe symptoms and complications when infected with a virus. Diabetes and high glucose levels are associated with increased complications, respiratory failure, and mortality in hospitalized patients with coronavirus.

Brazil has implemented a set of reforms over the past to improve the distribution of doctors, develop new forms of the service organization, introduce new financing models, and implement a range of quality improvement initiatives and policy frameworks to overcome risk factors such as obesity and emerging pandemic threats. The pandemic also highlighted opportunities for continuing and expanding innovations in the delivery of diabetes care, through virtual consultations between healthcare providers and people with diabetes, and the use of diabetes technology. Crisis management has created unprecedented interest in remote care from both patients and providers and removed many long-standing regulatory barriers. Thus, the COVID-19 outbreak increased the blood glucose monitoring market's growth.

Brazil Blood Glucose Monitoring Industry Segmentation

Blood Glucose Monitoring devices are used to diagnose both hyperglycemic and hypoglycemic conditions in diabetic patients. The Brazil Blood Glucose Monitoring Market is segmented into types (self-monitoring blood glucose devices (glucometer devices, test strips, and lancets) and continuous glucose monitoring devices (sensors and durables (receivers and transmitters))). The report offers the value (in USD million) and volume (in units million) for the above segments.

Type
Self-monitoring blood glucose devices
Glucometer Devices
Test Strips
Lancets
Continuous blood glucose monitoring devices
Sensors
Durables (Receivers and Transmitters)
Need A Different Region Or Segment?
Customize Now

Brazil Blood Glucose Monitoring Market Size Summary

The Brazil Blood Glucose Monitoring Market is poised for significant growth, driven by the increasing prevalence of diabetes and the heightened focus on diabetes management due to its association with severe COVID-19 outcomes. The market is characterized by a moderate level of fragmentation, with key players like Abbott and Medtronic leading through continuous innovation and strategic partnerships. The COVID-19 pandemic has accelerated the adoption of remote care and diabetes technology, creating new opportunities for market expansion. Brazil's healthcare reforms and policy frameworks have further supported the growth of diabetes care solutions, including blood glucose monitoring devices. The market is expected to benefit from advancements in continuous glucose monitoring (CGM) technologies, which offer real-time glucose readings and are becoming increasingly popular among diabetic patients, particularly those using insulin pumps.

The economic burden of diabetes in Brazil is substantial, with high healthcare costs associated with diabetes-related complications and comorbidities. Despite the challenges, the Brazilian Health System has made strides in providing necessary medications and supplies to manage diabetes effectively. The market's growth is also fueled by the rising demand for CGM devices, which are gaining traction due to their effectiveness in managing glucose levels for patients with frequent hypoglycemic events and those requiring continuous monitoring. Innovations in glucose sensing technologies, such as optical measurement and fluorescence sensing, are expected to enhance the market's offerings. As the diabetic population continues to grow, the Brazil Blood Glucose Monitoring Market is anticipated to expand, supported by technological advancements and strategic industry collaborations.

Explore More

Brazil Blood Glucose Monitoring Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

    3. 1.3 Market Restraints

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products and Services

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Type

      1. 2.1.1 Self-monitoring blood glucose devices

        1. 2.1.1.1 Glucometer Devices

        2. 2.1.1.2 Test Strips

        3. 2.1.1.3 Lancets

      2. 2.1.2 Continuous blood glucose monitoring devices

        1. 2.1.2.1 Sensors

        2. 2.1.2.2 Durables (Receivers and Transmitters)

Brazil Blood Glucose Monitoring Market Size FAQs

The Brazil Blood Glucose Monitoring Market size is expected to reach USD 629.61 million in 2024 and grow at a CAGR of 7.80% to reach USD 916.57 million by 2029.

In 2024, the Brazil Blood Glucose Monitoring Market size is expected to reach USD 629.61 million.

Brazil Blood Glucose Monitoring Market Report Snapshots

Brazil Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)